Navigation Links
New Canadian study finds drug coated heart stents to be safe:
Date:10/3/2007

'Effective in High Risk Angioplasty Patients'

TORONTO, Oct. 3 /PRNewswire/ - Much controversy has developed over the past year about the safety and potential complications of drug-eluting heart stents, increasing the risk of possible fatal blood clots, even years after an angioplasty procedure. However, a new Canadian study led by investigators from Ontario's Institute for Clinical Evaluative Sciences (ICES) and McMaster University's Program for Assessment of Technologies in Health, tells a different story.

Drug-eluting stents were found to be most effective in reducing the need for repeat angioplasty procedures or bypass surgery in angioplasty patients at the 'highest risk' for a renarrowing of the artery around the stent, without significantly increasing the rate of death or risk of heart attack. Lead Author, ICES Sr. Scientist, Dr. Jack Tu says, "This is good news, reassuring patients and cardiologists about the safety of drug-eluting stents when used in appropriate individuals. Our results also suggest physicians should be selective in using drug-eluting stents, offering them to angioplasty patients who are at the highest risk for repeat cardiac procedures."

Reporting in the October 4th issue of the prestigious New England Journal of Medicine, the large Canadian study conducted at ICES, in collaboration with cardiologists and researchers from Sunnybrook Health Sciences Centre and the University of Toronto, looked at over 3,700 unique matched pairs of Ontario patients who received drug-eluting stents (DES) or more conventional bare metal stents (BMS) during angioplasty. Using data from the Ontario Cardiac Care Network's (CCN) population-based angioplasty registry, and accounting for differences in patient characteristics, investigators analyzed the outcomes of patients having angioplasty in Ontario between December 2003 and March 2005 for the 'real-world' effectiveness of DES. The results:

- DES reduced the need for a
'/>"/>

SOURCE Institute for Clinical Evaluative Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Frozen Canadian baby stages miraculous recovery
2. Canadian Street Prostitutes Requests Protection
3. Rural Canadians travel far for specialists: study
4. Canadian Youth at risk of heart disease
5. Canadians flocking to India for quick and efficient medical treatment
6. CPHA Offers HIV Information Packages To Canadian Football League Teams
7. Insomnia Hits Many Canadians: Survey
8. Canadians Oblivious About COPD, A Debilitating Lung Disease
9. Disparity In Survival Rates In US and Canadian heart Patients
10. Canadian health on the decline, due to a drinking problem
11. Lack of facilities in emergency rooms, warn Canadian nurses!

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... new interactive anatomy education apps from Modal...ealth sciences learning opportunities for iPhone a...C (Vocus) November 27, 2009 -- Modality, Inc. an...ion of Wolters Kluwer Health, today announced the ...n the App Store. Clemente’s Anatomy, Rohen&r...
(Date:11/26/2009)...tetrathiomolybdate (TM) has been shown in studies ..., a disease caused by an overload of copper, and c...y little, however, is known about how the drug wor...Northwestern University researchers now has provid...ture of TM bound to copper-loaded metallochaperone...
(Date:11/26/2009)...avid Kim of the Live Life Again Center, a practice...of a growing number of physicians who are taking ...nnect with individuals who are interested in surgi... Dr. Kim is utilizing Facebook to share before-and...ith the community. , Dall...
(Date:11/25/2009)...25 When most people hea...ut a chiropractor can also give patients the help ...Joint, which is where your jaw (mandible) contacts...The most common symptoms associated with TMJ dysfu...of the jaw. But many other symptoms can be caused...
(Date:11/25/2009)...RNewswire/ - Sentinelle Medical Inc., a leading ma...ization software launches a suite of new leading e... imaging software platform at this year,s Radiolog...g in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, ... quality images generated by Sentinelle,s speciali...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
... 10 CMP India and CMP Information,The Netherlands...y,International Exhibition and Conference on Food ... is a part of the world-wide series of Fi Events,h...eptember 2006 for the first time and,was inaugurat...
...vide the most effective treatments for cancer pati...ive and specific early detection of the disease. ...Glycobiology Laboratory at UCD has developed a sys... which are attached either to proteins made by can...
... 9 Today, Congresswoman,Stephanie Tubbs Jones app...ents for Patients and Providers Act by a veto-proo..., "I am ecstatic that my Senate colleagues passed...viding continuing,protections to ensure access by ...
...uly 9 A lawsuit charges,pharmaceutical giant Pfiz...he public of potentially deadly side-effects assoc...nicline which is marketed under the trade name,Cha...death occurred only a few days before the informat...
...ay point to new targets for treatment, study says ...A gene mutation linked to one family,s hereditary ...ind better ways to predict, prevent and treat the ... large family with an inherited form of atrial fib...
...J. Wilson, President and CEO of the American,Assoc...ble medical,equipment manufacturers and providers ...icials at the revelations that scam artists used i...presented by,the American Association for Homecare...
Other Medicine News:Health News:CMP is Back This Year with Loads of Innovative Ideas and Varieties of Food Ingredients 2Health News:A short and sweet diagnosis for cancer? 2Health News:Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris 2Health News:Gene Mutation Tied to Inherited Atrial Fibrillation 2Health News:Home Medical Equipment Providers Are Appalled by 'Dead-Doctor' Scam, Strongly Support Anti-Fraud Efforts to Protect Medicare System 2Health News:Home Medical Equipment Providers Are Appalled by 'Dead-Doctor' Scam, Strongly Support Anti-Fraud Efforts to Protect Medicare System 3
(Date:11/25/2009)...Colo., Nov. 25 Heska Cor... advanced diagnostic and specialty products to t... with Roche Diagnostics Corporation for the supply...for the veterinary market. ,, (Logo: http:...) ,, "Heska and Roche share the same passion fo...
(Date:11/25/2009)...TAFA, Switzerland, Nov. 25 From N... innovative hearing solutions, presented the secon...e, focusing on the special needs of the older popu...perts in aging and audiology from around the world...th older people with hearing loss for an opportuni...
(Date:11/25/2009)...K, Md., Nov. 25 Remediu...g cream-like foam that stops severe bleeding, won ...rity Idea category of the Global Security Challeng...lected from more than 100 entries from around the ...the GSC Security Summit conference held at the Lon...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3AFSCME President McEntee 3A 22Finance Committee Health Care Bill is Deeply Flawed 22 57421 1For the Color Blind a Ray of Hope 57416 1For the Color Blind a Ray of Hope 57416 2Prime Staffing Awarded Certification from The Joint Commission 57411 1Prime Staffing Awarded Certification from The Joint Commission 57411 2
...med,Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a deve...ced today that it has concluded a proof of concept...RMD-0802, using its,proprietary technology. Eight ...ifferent formulations. , The insulin supposito...glucose lowering effect. The suppositories were we...
... Indication is June 3, 2009 - , , EXTON, Pa., Fe...orated (Nasdaq: VPHM ) today announced that the ...d priority review for Cinryze C1 Inhibitor (human)...gioedema (HAE). The supplemental Biologics Licens...mber 1, 2008, was based on a re-analysis and resu...
Other Medicine Technology:Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6
...precise requirements of blood banking and processi... meets American Association of Blood Banks (AABB),...& Drug Administration (FDA) standards. Refrigerato...ure alarm systems that alert you of critical power...
Blood Storage Refrigerator TBR-200-1-GD
Testosterone ELISA
Ultra-Sensitive Testosterone EIA
Medicine Products: